# Efficacy and Safety of Upatinib in the Treatment of Active Anal Fistulas in Crohn's Disease

> **NCT06902987** · PHASE1 · RECRUITING · sponsor: **Sixth Affiliated Hospital, Sun Yat-sen University** · enrollment: 27 (estimated)

## Conditions studied

- Crohn's Diseases
- Active Anal Fistula
- Upadacitinib

## Interventions

- **DRUG:** Upadacitinib

## Key facts

- **NCT ID:** NCT06902987
- **Lead sponsor:** Sixth Affiliated Hospital, Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-17
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2025-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06902987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06902987, "Efficacy and Safety of Upatinib in the Treatment of Active Anal Fistulas in Crohn's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06902987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*